Can you provide the last earnings date for TREACE MEDICAL CONCEPTS INC?
TREACE MEDICAL CONCEPTS INC (TMCI) last reported earnings on 2/27/2026.
TREACE MEDICAL CONCEPTS INC (TMCI) Earnings History & Surprises
NASDAQ:TMCI • US89455T1097
Current stock price
1.46 USD
+0.11 (+8.15%)
At close:
1.4731 USD
+0.01 (+0.9%)
After Hours:
TMCI Earnings overview
Past quarterly earnings results for TREACE MEDICAL CONCEPTS INC (TMCI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.27
- Revenue Estimate
- 47.325M
Last Reported
Most Recent- Release Date
- Feb 27, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.15
- EPS Surprise
- 1.96%
- Revenue Surprise
- -0.16%
Beat Rate
Last 8 Quarters 75%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.15 | -0.15 | 1.96% | -1,400.00% | 62.519M | 62.618M | -0.16% | -9.01% |
| Q3 2025 | -0.26 | -0.29 | 8.96% | -4.00% | 50.214M | 50.726M | -1.01% | 11.37% |
| Q2 2025 | -0.28 | -0.29 | 4.79% | 3.45% | 47.387M | 47.994M | -1.26% | 6.60% |
| Q1 2025 | -0.25 | -0.31 | 18.69% | 16.67% | 52.57M | 53.111M | -1.02% | 2.86% |
| Q4 2024 | -0.01 | -0.04 | 74.58% | 90.00% | 68.708M | 68.5M | 0.30% | 10.44% |
| Q3 2024 | -0.25 | -0.28 | 9.78% | 10.71% | 45.086M | 44.354M | 1.65% | 10.62% |
| Q2 2024 | -0.29 | -0.30 | 1.96% | -45.00% | 44.455M | 43.86M | 1.36% | 5.96% |
| Q1 2024 | -0.30 | -0.31 | 2.89% | -30.43% | 51.108M | 50.046M | 2.12% | 21.12% |
| Q4 2023 | -0.10 | -0.09 | -10.69% | -25.00% | 62.212M | 61.761M | 0.73% | 25.00% |
| Q3 2023 | -0.28 | -0.27 | -5.00% | -27.27% | 40.758M | 42.896M | -4.98% | 23.28% |
| Q2 2023 | -0.20 | -0.24 | 17.73% | 35.48% | 41.953M | 41.665M | 0.69% | 39.98% |
| Q1 2023 | -0.23 | -0.23 | 1.24% | -43.75% | 42.195M | 40.03M | 5.41% | 45.25% |
| Q4 2022 | -0.08 | -0.14 | 43.98% | 33.33% | 49.77M | 45.645M | 9.04% | 48.83% |
| Q3 2022 | -0.22 | -0.29 | 24.98% | -83.33% | 33.06M | 30.668M | 7.80% | 52.91% |
| Q2 2022 | -0.31 | -0.21 | -48.25% | -210.00% | 29.97M | 29.206M | 2.62% | 45.13% |
| Q1 2022 | -0.16 | -0.21 | 22.54% | -128.57% | 29.05M | 26.554M | 9.40% | 55.26% |
| Q4 2021 | -0.12 | -0.01 | -2,252.94% | - | 33.44M | 32.912M | 1.60% | 38.76% |
| Q3 2021 | -0.12 | -0.12 | 1.96% | - | 21.62M | 21.42M | 0.93% | 51.51% |
| Q2 2021 | -0.10 | -0.12 | 18.30% | - | 20.65M | 19.312M | 6.93% | 166.80% |
| Q1 2021 | -0.07 | -0.06 | -14.38% | - | 18.71M | 19.142M | -2.26% | 66.16% |
| Q4 2020 | - | - | 24.1M | - | - | |||
| Q3 2020 | - | - | 14.27M | - | - | |||
| Q2 2020 | - | - | 7.74M | - | - | |||
| Q1 2020 | - | - | 11.26M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
26.76%
Max EPS beat (4)
74.58%
Min EPS beat (4)
4.79%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-0.75%
Max Revenue beat (4)
0.30%
Min Revenue beat (4)
-1.26%
Analysis
In the last 4 quarters, TMCI has consistently beaten EPS estimates in all releases
TMCI has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, TMCI has beaten the EPS estimates by 26.8% on average.
In the last 4 quarters, TMCI reported -0.7% below the revenue estimates on average.
Related analysis
TREACE MEDICAL CONCEPTS INC / TMCI Earnings FAQ
Did TREACE MEDICAL CONCEPTS INC (TMCI) beat earnings estimates last quarter?
TREACE MEDICAL CONCEPTS INC (TMCI) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often TREACE MEDICAL CONCEPTS INC beats earnings estimates?
In the last 4 quarters, TREACE MEDICAL CONCEPTS INC (TMCI) has beaten EPS estimates in 4 out of 4 releases.